+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Canada Animal Vaccine Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: Canada
  • Orion Market Research Private Limited
  • ID: 4969034
Canada Animal Vaccine Market Size, Share & Trends Analysis Report, By Type (Porcine Vaccines, Poultry Vaccines, Livestock Vaccines, Aquaculture Vaccines, Companion Animal Vaccines, and Other Animal Vaccines) By Technology (Live Attenuated Vaccine, Killed/Inactive Vaccine, Recombinant Vaccine, Vectored Vaccine, Subunit Vaccine, DNA Vaccine, Chimeric Vaccine, and Others) and Forecast, 2019-2025.

Canada animal vaccine market is estimated to grow at a CAGR of around 7.8% during the forecast period. The major factors contributing to the growth of the market include the increasing adoption of pets among households. As per the Food and Agriculture Organization of the United Nations (FAO), the production of chickens in Canada was 170,442, per 1000 head in 2017 and 170,106, per 1000 head in 2016. This growth in chickens results in the emerging focus on proper health of poultry birds, which in turn, is promoting the growth of the market in Canada.

Moreover, Canadian pet health regulatory norms are such that a person needs to keep a health certificate to carry the pet outside Canada. It ensures compulsory vaccination for the pets. This is expected to further promote the demand for animal vaccines in Canada, thereby promoting the growth of the market in the near future. With the growing awareness among people increases coupled with increasing animal healthcare expenditure, the demand for animal vaccines in Canada is further estimated to grow during the forecast period.

Some crucial players in the Canada animal vaccine market include Zoetis, Inc., Elanco, Merck & Co., Inc., Novartis International AG and Vetoquinol SA. To survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market. For instance, in December 2019, Vétoquinol acquired animal health business assets of VETCOM 1979 INC. The VETCOM 1979 INC. animal health business comprises annual revenue of nearly $1.1 million. This will enable Vétoquinol to reinforce their presence in Canada in the companion animal market.

Research Methodology

The market study of the Canada animal vaccine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for pharmaceuticals companies, veterinary companies, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation
  • Canada Animal Vaccine Market Research and Analysis, By Type
  • Canada Animal Vaccine Market Research and Analysis, By Technology

The Report Covers
  • Comprehensive research methodology of the Canada animal vaccine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Canada animal vaccine market.
  • Insights about market determinants which are stimulating the Canada animal vaccine market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Canada Animal Vaccine Market by Type
5.1.1. Porcine Vaccines
5.1.2. Poultry Vaccines
5.1.3. Livestock Vaccines
5.1.4. Aquaculture Vaccines
5.1.5. Companion Animal Vaccines
5.1.6. Other Animal Vaccines
5.2. Canada Animal Vaccine Market by Technology
5.2.1. Live Attenuated Vaccine
5.2.2. Killed/Inactive Vaccine
5.2.3. Recombinant Vaccine
5.2.4. Vectored Vaccine
5.2.5. Subunit Vaccine
5.2.6. DNA Vaccine
5.2.7. Chimeric Vaccine
5.2.8. Others
6. Company Profiles
6.1. Bimeda Holdings PLC
6.2. Boehringer Ingelheim International GmbH
6.3. Elanco
6.4. Merck & Co., Inc.
6.5. Neogen Corp.
6.6. Novartis International AG
6.7. VBI Vaccines Inc.
6.8. Vetoquinol SA
6.9. Virbac SA
6.10. Zoetis, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bimeda Holdings PLC
  • Boehringer Ingelheim International GmbH
  • Elanco
  • Merck & Co., Inc.
  • Neogen Corp.
  • Novartis International AG
  • VBI Vaccines Inc.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis, Inc.